History and prospects for the use of morphine in clinical practice: literature review

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The authors analyzed various studies on acute and chronic pain syndrome treatment. This review provides brief historical data on the discovery and use of morphine from ancient times to present. Morphine remains one of the most common painkillers worldwide and has a rich history dating back more than 200 years. Its basic properties, pharmacokinetics, pharmacodynamics, and principles of use are discussed. No drug has had such an impact on society as morphine because of its medical use as a pain reliever and its illicit use as a drug of addiction and abuse. This review includes the main modern recommendations for the treatment of acute and chronic pain, particularly from the World Health Organization for the treatment of chronic pain and the Procedure-Specific Postoperative Pain Management (PROSPECT) group for the treatment of postoperative pain in various surgical interventions. The types of opioids and their clinical use are described, and the authors’ opinion on the current use of morphine for treating acute and chronic pain syndrome is presented.

About the authors

Yurii S. Raspopin

Voino-Yasenetsky Krasnoyarsk State Medical University; Krasnoyarsk Regional Clinical Center Krasnoyarsk of Maternal and Child Health

Author for correspondence.
Email: oar24@mail.ru
ORCID iD: 0000-0001-5550-1628
SPIN-code: 6793-7478
Scopus Author ID: 57223183048

MD, Cand. Sci. (Medicine)

Russian Federation, Krasnoyarsk; Krasnoyarsk

Efim M. Shifman

Vladimirsky Moscow Regional Research Clinical Institute; Pirogov Russian National Research Medical University

Email: eshifman@mail.ru
ORCID iD: 0000-0002-6113-8498
SPIN-code: 4582-8494
Scopus Author ID: 6507655298
ResearcherId: AAY-3981-2020

MD, Dr. Sci. (Medicine), professor

Russian Federation, Moscow; Moscow

Daria A. Feoktistova

Voino-Yasenetsky Krasnoyarsk State Medical University

Email: keniw2014@yandex.ru
ORCID iD: 0000-0002-3901-2696

student

Russian Federation, Krasnoyarsk

References

  1. Turnaturi R, Piana S, Spoto S, et al. From Plant to Chemistry: Sources of Active Opioid Antinociceptive Principles for Medicinal Chemistry and Drug Design. Molecules. 2023;28(20):7089. doi: 10.3390/molecules28207089
  2. Tang J, Churilov L, Tan CO, et al. Intrathecal morphine is associated with reduction in postoperative opioid requirements and improvement in postoperative analgesia in patients undergoing open liver resection. BMC Anesthesiol. 2020;20(1):207. doi: 10.1186/s12871-020-01113-8
  3. Sertürner FWA. Brockhaus Encyclopedia. Mannheim: Wissen Media Verlag; 2009. (In German)
  4. Klockgether-Radke AP. F.W. Sertürner and the discovery of morphine. 200 years of pain therapy with opioids. Anasthesiol Intensivmed Notfallmed Schmerzther. 2002;37(5):244–249. (In German). doi: 10.1055/s-2002-30132
  5. Wicks C, Hudlicky T, Rinner U. Morphine alkaloids: History, biology, and synthesis. Alkaloids Chem Biol. 2021;(86):145–342. doi: 10.1016/bs.alkal.2021.04.001
  6. Jurna I. Sertürner and morphine — a historical vignette. Schmerz. 2003;17(4):280–283. (In German). doi: 10.1007/s00482-003-0220-3
  7. Manske RHF, Holmes HL, editors. The alkaloids: chemistry and physiology. New York: Elsevier; 2014.
  8. Abuzarova GR, Khoronenko VE, Sarmanaeva RR. Background and perspectives of opioid analgesics for the treatment of chronic pain in cancer patients in Russia. Russian Journal of Anеsthesiology and Reanimatology. 2015;60(1):19–25. EDN: TTCHHZ
  9. Bulletin on Narcotics: A Century of International Drug Control United Nations Publications. Vienna: United Nations; 2010.
  10. Goldstein A, Lowney LI, Pal BK. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc Natl Acad Sci U S A. 1971;68(8):1742–1747. doi: 10.1073/pnas.68.8.1742
  11. Pert CB, Snyder SH. Opiate receptor: demonstration in nervous tissue. Science. 1973;179(4077):1011–1014. doi: 10.1126/science.179.4077.1011
  12. Davis MP, Walsh D. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer. 2001;9(2):73−83. doi: 10.1007/s005200000180
  13. Rezaei M, Naghavi MR, Hosseinzadeh A, et al. Spatiotemporal oscillations of morphinan alkaloids in opium poppy. J Biosci. 2018;43(2):391–405.
  14. Rinner U, Hudlicky T. Synthesis of morphine alkaloids and derivatives. Top Curr Chem. 2012;(309):33–66. doi: 10.1007/128_2011_133
  15. Jacobsen LS, Olsen AK, Sjøgren P, Jensen NH. Morphine-induced hyperalgesia, allodynia and myoclonus — new side-effects of morphine? Ugeskr Laeger. 1995;157(23):3307–3310. (In Danish)
  16. Vanegas G, Ripamonti C, Sbanotto A, De Conno F. Side effects of morphine administration in cancer patients. Cancer Nurs. 1998;21(4):289–297. doi: 10.1097/00002820-199808000-00011
  17. O’Neill A, Lirk P. Multimodal Analgesia. Anesthesiol Clin. 2022;40(3):455–468. doi: 10.1016/j.anclin.2022.04.002
  18. PROSPECT [Internet]. ESRA Europe; 2002–2024 [cited 2024 Feb 4]. Available from: https://esraeurope.org/pain-management/
  19. Chalil A, Staudt MD, Harland TA, et al. A safety review of approved intrathecal analgesics for chronic pain management. Expert Opin Drug Saf. 2021;20(4):439–451. doi: 10.1080/14740338.2021.1889513
  20. Laux-Biehlmann A, Mouheiche J, Vérièpe J, Goumon Y. Endogenous morphine and its metabolites in mammals: history, synthesis, localization and perspectives. Neuroscience. 2013;(233):95–117. doi: 10.1016/j.neuroscience.2012.12.013
  21. Morphine Liposomal — SkyePharma: C 0401, D 0401, morphine — DepoFoam, SKY 0401. Drugs R D. 2003;4(6):373–375. doi: 10.2165/00126839-200304060-00009
  22. Cooper TE, Chen J, Wiffen PJ, et al. Morphine for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;5(5):CD011669. doi: 10.1002/14651858.CD011669.pub2
  23. Hanks GW. Morphine pharmacokinetics and analgesia after oral administration. Postgrad Med J. 1991;67(Suppl 2):S60–S63.
  24. Kullmann T, Sipőcz I, Csikós Á, Pintér T. New option in the management of cancer pain in Hungary: short acting oral opioid therapy. Orv Hetil. 2015;156(25):1003–1006. (In Hungarian). doi: 10.1556/650.2015.30171
  25. Deer TR, Pope JE, Hayek SM, et al. The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines. Neuromodulation. 2017;20(2):96–132. doi: 10.1111/ner.12538. Erratum in: Neuromodulation. 2017;20(4):405–406.
  26. Deer TR, Pope JE, Hanes MC, McDowell GC. Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options. Pain Med. 2019;20(4):784–798. doi: 10.1093/pm/pny132
  27. Yiping S, Jiayi S, Guang H, et al. The efficacy and safety of epidural morphine / hydromorphone in the treatment of intractable postherpetic neuralgia: A single-center, double-blinded, randomized controlled, prospective, and non-inferiority study. Front Pharmacol. 2022;(13):1051357. doi: 10.3389/fphar.2022.1051357
  28. Tang CY, Tu YK, Kao MC, et al. Effects of opioids administered via intravenous or epidural patient-controlled analgesia after caesarean section: A network meta-analysis of randomised controlled trials. EClinicalMedicine. 2022;(56):101787. doi: 10.1016/j.eclinm.2022.101787
  29. Roofthooft E, Joshi GP, Rawal N, et al. PROSPECT guideline for elective caesarean section: updated systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia. 2021;76(5):665–680. doi: 10.1111/anae.15339
  30. Yen D, Turner K, Mark D. Is a single low dose of intrathecal morphine a useful adjunct to patient-controlled analgesia for postoperative pain control following lumbar spine surgery? A preliminary report. Pain Res Manag. 2015;20(3):129–132. doi: 10.1155/2015/761390
  31. Bang YJ, Lee EK, Kim CS, et al. The Effect of Intrathecal Morphine on Postoperative Opioid Consumption in Patients Undergoing Abdominal Surgery for Gynecologic Malignancy: A Randomized Sham-Controlled Trial. Anesth Analg. 2023;137(3):525–533. doi: 10.1213/ANE.0000000000006358

Copyright (c) 2024 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies